Related Experiment Video

Updated: Mar 13, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.2K

[Damage-associated molecular patterns and liver failure]

Y Y Yan1, S Lin, Y Y Zhu

  • 1Liver Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|October 30, 2016
PubMed

Insights

Damage-associated molecular patterns (DAMPs) are molecules released by damaged cells that influence immune responses. Understanding DAMPs in liver failure offers new diagnostic and treatment strategies.

Area of Science:

  • Immunology
  • Hepatology
  • Molecular Biology

Background:

  • Damage-associated molecular patterns (DAMPs) are intracellular molecules released by stressed or dying cells.
  • These molecules possess immunoregulatory functions, influencing autoimmunity and immune tolerance through pattern recognition receptors.
  • Known DAMPs include extracellular histone, HMGB1, cfDNA, IL-18, IL-32, uric acid, and mitochondrial transcription factors.

Purpose of the Study:

  • To summarize the concept and mechanisms of DAMPs.
  • To explore the role of DAMPs in the pathophysiology of liver failure.
  • To highlight the potential of DAMPs in liver failure diagnosis and treatment.

Main Methods:

  • Literature review and conceptual summary.
  • Analysis of DAMPs' involvement in cellular damage and immune activation.
  • Discussion of DAMPs' impact on liver failure progression.

Main Results:

  • DAMPs are key mediators linking cell damage to immune responses in liver failure.
  • Specific DAMPs identified play critical roles in disease pathogenesis.
  • Understanding DAMPs provides novel insights into liver failure mechanisms.

Conclusions:

  • DAMPs are crucial in understanding the complex processes underlying liver failure.
  • Targeting DAMPs presents a promising avenue for developing new therapeutic strategies for liver failure.
  • Further research into DAMPs' specific roles can advance liver disease management.

More Related Videos

Cell Type-specific Gene Expression Profiling in the Mouse Liver10:06

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

8.3K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

55.1K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.6K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
309
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K